Children's Mercy Kansas City and Geneyx Inc. Announce Collaboration to Advance Genomic Research and Analysis

Children's Mercy Kansas City, one of the leading independent pediatric health organizations, and Geneyx Inc. are pleased to announce a collaboration aimed at advancing genomic research and analysis. This collaboration formalized through a Master Software Subscription and Services Agreement, enables Children's Mercy to utilize Geneyx Analysis in its research institute to analyze, interpret, annotate, and report Long Read sequencing data originated by 5-base HiFi sequencing of PacBio technology.

Children's Mercy is the first healthcare system to use this world's most advanced genomic sequencing technology in the clinical setting to accelerate diagnoses for even more patients and families.

The cutting-edge technology replaces rapid exome, chromosomal microarray analysis, and other conventional diagnostic testing as a first-line assessment for the most critically ill patients in the hospital with a strong suspicion of genetic disease.

"We are excited about this collaboration that signifies a significant step forward in leveraging cutting-edge technology to further genomic research and clinical care," said Emily Farrow, PhD, CGC, FACMG, Assistant Clinical Director, Clinical Genetics, Children's Mercy Kansas City. Geneyx Analysis will play a crucial role in enhancing our ability to analyze and interpret long read genomic data, ultimately leading to advancements in pediatric healthcare."

"We are thrilled to partner with Children's Mercy in their mission to improve pediatric healthcare through genomic training, research and analysis" said David Yizhar, CEO at Geneyx Inc. "This collaboration highlights the growing importance of innovative technologies in driving progress in the field of genomics."

"We are encouraged to see Geneyx and Children's Mercy Kansas City leverage the foundational HiFi sequencing benefits of higher accuracy and longer reads," said Christian Henry, President and Chief Executive Officer of PacBio. "Geneyx, a PacBio Compatible Partner, brings informatics solutions to accelerate genomic understanding, which may ultimately offer insights to Children's Mercy clinicians to better impact rare pediatric diseases."

Children's Mercy is providing a 4-day short course on next generation sequencing and analysis on June 10-13. The course features hands-on workshop analysis, including long read HiFi sequencing data. In-person and virtual attendance options are available.